Favorable outcome of allogeneic bone marrow transplantation in the treatment of pediatric osteosarcoma in the metastatic stage - clinical observation

S. Bogatyrev

Genes & Cells ›› 2006, Vol. 1 ›› Issue (2) : 25 -26.

PDF
Genes & Cells ›› 2006, Vol. 1 ›› Issue (2) : 25 -26. DOI: 10.23868/gc205282
Cell technology
research-article

Favorable outcome of allogeneic bone marrow transplantation in the treatment of pediatric osteosarcoma in the metastatic stage - clinical observation

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
S. Bogatyrev. Favorable outcome of allogeneic bone marrow transplantation in the treatment of pediatric osteosarcoma in the metastatic stage - clinical observation. Genes & Cells, 2006, 1(2): 25-26 DOI:10.23868/gc205282

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Weiden P.L., Flournoy N., Thomas E.D. et al. Antileukemic effect of graft— versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979, 300:1068-73.

[2]

Moscovitch M„ Slavin S. Anti-tumor effects of allogeneic bone marrow transplantation in [NZB X NZW)F1 hybrids with spontaneous lymphosarcoma. J. Immunol. 1984; 132(2): 997-1000.

[3]

Barnes D.W.H., Loutit J.F. Treatment of murine leukaemia with X-rays and homologous bone marrow. Br. J. Haematol. 1957; 3: 241-52

[4]

Carnevale-Schianca F., Ricchiardi A., Capaldi A. et al. Allogeneic hemopoietic stem cell transplantation in solid tumors. Transplant. Proc. 2005; 37(6): 2664-6.

[5]

Baron F., Maris M.B., Sandmaier B.M. et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J. Clin. Oncol. 2005; 23(9): 1993-2003.

[6]

Wang L.L. Biology of osteogenic sarcoma. Cancer J. 2005; 11(4): 294-305.

[7]

Nagarajan R., Clohisy D., Weigel B. New paradigms for therapy for osteosarcoma. Curr. Oncol. Rep. 2005; 7(6): 410-4.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

76

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/